Pharming Group(GB:0QCO)
€1.14-0.02 (-1.89%)
GB:0QCO
Pharming Group financials statements
€1.14
At close:-0.02 (-1.89%)
Pharming Group (0QCO) Financial Statements
5 Followers
Pharming Group Financial Overview
Pharming Group's market cap is currently €807.58M. The company's EPS TTM is €0.04; its P/E ratio is 35.72; Pharming Group is estimated to report earnings on March 18, 2027, and the estimated EPS forecast is €0.01. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 376.13M | € 297.07M | € 245.32M | € 205.62M | € 198.87M |
| Gross Profit | € 330.63M | € 261.80M | € 220.10M | € 188.06M | € 165.73M |
| Operating Income | € 20.88M | € -3.67M | € -4.88M | € 18.23M | € 19.01M |
| EBITDA | € 34.78M | € 7.55M | € 9.88M | € 33.53M | € 33.76M |
| Net Income | € 2.97M | € -11.84M | € -10.55M | € 13.67M | € 15.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 179.88M | € 167.82M | € 213.42M | € 208.58M | € 191.92M |
| Total Assets | € 500.02M | € 400.61M | € 462.85M | € 425.80M | € 397.42M |
| Total Debt | € 115.79M | € 112.26M | € 171.54M | € 167.69M | € 161.76M |
| Net Debt | € -30.29M | € 57.34M | € 109.80M | € -40.89M | € -29.41M |
| Total Liabilities | € 222.89M | € 178.85M | € 244.07M | € 221.16M | € 204.45M |
| Stockholders' Equity | € 277.10M | € 221.76M | € 218.78M | € 204.64M | € 192.92M |
| Cash Flow | |||||
| Free Cash Flow | € 51.18M | € -2.58M | € -18.77M | € 20.92M | € 22.86M |
| Operating Cash Flow | € 51.96M | € -1.86M | € -17.30M | € 22.90M | € 31.58M |
| Investing Cash Flow | € 19.13M | € 32.74M | € -129.39M | € 5.32M | € -23.06M |
| Financing Cash Flow | € 15.03M | € -35.63M | € -1.04M | € -4.98M | € -22.54M |
Currency in EUR

